• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细菌素:胃肠道的守护菌。

Bacteriocins: Curial guardians of gastrointestinal tract.

机构信息

Key Laboratory for Food Microbial Technology of Zhejiang Province, College of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou, Zhejiang, People's Republic of China.

Department of Food Science, University of Massachusetts Amherst, Amherst, Massachusetts, USA.

出版信息

Compr Rev Food Sci Food Saf. 2024 Jan;23(1):e13292. doi: 10.1111/1541-4337.13292.

DOI:10.1111/1541-4337.13292
PMID:38284593
Abstract

The human gastrointestinal (GI) tract microbiome secretes various metabolites that play pivotal roles in maintaining host physiological balance and influencing disease progression. Among these metabolites, bacteriocins-small, heat-stable peptides synthesized by ribosomes-are notably prevalent in the GI region. Their multifaceted benefits have garnered significant interest in the scientific community. This review comprehensively explores the methods for mining bacteriocins (traditional separation and purification, bioinformatics, and artificial intelligence), their effects on the stomach and intestines, and their complex bioactive mechanisms. These mechanisms include flora regulation, biological barrier restoration, and intervention in epithelial cell pathways. By detailing each well-documented bacteriocin, we reveal the diverse ways in which bacteriocins interact with the GI environment. Moreover, the future research direction is prospected. By further studying the function and interaction of intestinal bacteriocins, we can discover new pharmacological targets and develop drugs targeting intestinal bacteriocins to regulate and improve human health. It provides innovative ideas and infinite possibilities for further exploration, development, and utilization of bacteriocins. The inevitable fact is that the continuously exploration of bacteriocins is sure to bring the promising future for demic GI health understanding and interference strategy.

摘要

人类胃肠道(GI)微生物群分泌各种代谢物,这些代谢物在维持宿主生理平衡和影响疾病进展方面发挥着关键作用。在这些代谢物中,细菌素——核糖体合成的小而热稳定的肽——在 GI 区域特别普遍。它们多方面的益处引起了科学界的极大兴趣。

本综述全面探讨了细菌素的挖掘方法(传统的分离和纯化、生物信息学和人工智能)、它们对胃和肠道的影响以及它们复杂的生物活性机制。这些机制包括菌群调节、生物屏障修复和上皮细胞途径的干预。通过详细描述每个有充分文献记录的细菌素,我们揭示了细菌素与 GI 环境相互作用的多种方式。此外,还展望了未来的研究方向。通过进一步研究肠道细菌素的功能和相互作用,我们可以发现新的药理靶点,并开发针对肠道细菌素的药物来调节和改善人类健康。它为细菌素的进一步探索、开发和利用提供了创新的思路和无限的可能性。不可避免的事实是,对细菌素的不断探索必将为了解和干预 GI 健康带来充满希望的未来。

相似文献

1
Bacteriocins: Curial guardians of gastrointestinal tract.细菌素:胃肠道的守护菌。
Compr Rev Food Sci Food Saf. 2024 Jan;23(1):e13292. doi: 10.1111/1541-4337.13292.
2
Diversity and dynamics of bacteriocins from human microbiome.人体微生物组中细菌素的多样性和动态。
Environ Microbiol. 2015 Jun;17(6):2133-43. doi: 10.1111/1462-2920.12662. Epub 2014 Dec 17.
3
The microbiome-shaping roles of bacteriocins.细菌素在微生物组形成中的作用。
Nat Rev Microbiol. 2021 Nov;19(11):726-739. doi: 10.1038/s41579-021-00569-w. Epub 2021 Jun 1.
4
Harnessing bacteriocin biology as targeted therapy in the GI tract.利用细菌素生物学作为胃肠道的靶向治疗方法。
Gut Microbes. 2016 Nov;7(6):512-517. doi: 10.1080/19490976.2016.1233089. Epub 2016 Sep 13.
5
Food and gut originated bacteriocins involved in gut microbe-host interactions.食物和肠道来源的细菌素参与肠道微生物-宿主相互作用。
Crit Rev Microbiol. 2023 Aug;49(4):515-527. doi: 10.1080/1040841X.2022.2082860. Epub 2022 Jun 17.
6
A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice.一种评估细菌素对小鼠肠道微生物群影响的方法。
J Vis Exp. 2017 Jul 25(125):56053. doi: 10.3791/56053.
7
G.I. pros: Antimicrobial defense in the gastrointestinal tract.胃肠道中的抗菌防御。
Semin Cell Dev Biol. 2019 Apr;88:129-137. doi: 10.1016/j.semcdb.2018.02.001. Epub 2018 Feb 12.
8
Demystifying Bacteriocins of Human Microbiota by Genome Guided Prospects: An Impetus to Rekindle the Antimicrobial Research.通过基因组引导的前景揭示人类微生物群的细菌素:重振抗菌研究的动力
Curr Protein Pept Sci. 2022;23(12):811-822. doi: 10.2174/1389203724666221019111515.
9
Bacteriocins: Recent Advances in its Application as an Antimicrobial Alternative.细菌素:作为抗菌替代品应用的最新进展
Curr Pharm Biotechnol. 2022;23(8):1028-1040. doi: 10.2174/1389201022666210907121254.
10
Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: bacteriocins and conjugated linoleic acid.肠道细菌产生的生物活性物质作为解释益生菌机制的基础:细菌素和共轭亚油酸。
Int J Food Microbiol. 2012 Jan 16;152(3):189-205. doi: 10.1016/j.ijfoodmicro.2011.05.025. Epub 2011 Jun 14.

引用本文的文献

1
Bioinformatics-driven discovery of skin microbiota bacteriocins as potential antibiotics and probiotics.生物信息学驱动发现皮肤微生物群细菌素作为潜在抗生素和益生菌。
J Antibiot (Tokyo). 2025 Jul 24. doi: 10.1038/s41429-025-00847-2.
2
Efficacy and safety of Latilactobacillus sakei LB-P12 in patients with knee osteoarthritis: an exploratory randomized, double-blind, placebo-controlled clinical trial.清酒乳杆菌LB-P12治疗膝骨关节炎患者的疗效和安全性:一项探索性随机双盲安慰剂对照临床试验
Sci Rep. 2025 Jul 17;15(1):25980. doi: 10.1038/s41598-025-11250-0.
3
Harnessing the human gut microbiota: an emerging frontier in combatting multidrug-resistant bacteria.
利用人类肠道微生物群:对抗多重耐药细菌的新前沿。
Front Immunol. 2025 Mar 17;16:1563450. doi: 10.3389/fimmu.2025.1563450. eCollection 2025.
4
Review on the Function, Substrate Affinity, and Potential Application of Bile Salt Hydrolase Originated from Probiotic Strains of , , and .源自、和益生菌菌株的胆汁盐水解酶的功能、底物亲和力及潜在应用综述
Food Sci Anim Resour. 2025 Mar;45(2):353-374. doi: 10.5851/kosfa.2025.e1. Epub 2025 Mar 1.
5
The Bacteriocins Produced by Lactic Acid Bacteria and the Promising Applications in Promoting Gastrointestinal Health.乳酸菌产生的细菌素及其在促进胃肠道健康方面的应用前景
Foods. 2024 Dec 2;13(23):3887. doi: 10.3390/foods13233887.
6
The clinical praxis of bacteriocins as natural anti-microbial therapeutics.细菌素作为天然抗菌治疗剂的临床实践。
Arch Microbiol. 2024 Oct 30;206(11):451. doi: 10.1007/s00203-024-04152-8.
7
Microbes as medicine.微生物作为药物。
Ann N Y Acad Sci. 2024 Nov;1541(1):63-82. doi: 10.1111/nyas.15237. Epub 2024 Oct 11.
8
Whole-genome sequencing and characterization of human fecal isolate LC130 from NORDBIOTIC collection.来自北欧生物菌群库的人类粪便分离株LC130的全基因组测序与特征分析。
Microbiol Resour Announc. 2024 Aug 13;13(8):e0050724. doi: 10.1128/mra.00507-24. Epub 2024 Jul 2.
9
The Progress of the Biotechnological Production of Class IIa Bacteriocins in Various Cell Factories and Its Future Challenges.各类细胞工厂中 IIa 类细菌素的生物技术生产进展及其未来挑战。
Int J Mol Sci. 2024 May 26;25(11):5791. doi: 10.3390/ijms25115791.